Global Neurovascular Interventional Devices for Hemorrhagic Stroke Market

Published August 2021 | 11 Pages | 14 Exhibits | Forecasts Through 2025

snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Overview

This report from Life Science Intelligence provides the latest market data for the Global Neurovascular Interventional Devices for Hemorrhagic Stroke Market. Information covered by this report includes:

  • unit volumes & pricing forecast from 2020-2025
  • analyses of the leading companies, and
  • global market share analysis.

This report covers the impact of COVID-19 on the neurovascular interventional devices for hemorrhagic stroke market, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and others. The report provides insights into trends, drivers, and limiters of the neurovascular devices for hemorrhagic stroke market, as well as highlights potential opportunities.

Companies Covered

Abbott

Boston Scientific

Cerenovus/J&J

Cordis Cardinal Health

Evasc

Microport

Microvention/Terumo

Micrus

Penumbra

Target/Stryker

Ready to get started?

We help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.